Abstract

Transmembrane AMPA receptor regulatory proteins (TARPs) and germ cell-specific gene 1-like protein (GSG1L) are claudin-type AMPA receptor (AMPAR) auxiliary subunits that profoundly regulate glutamatergic synapse strength and plasticity. While AMPAR-TARP complexes have been extensively studied, less is known about GSG1L-containing AMPARs. Here, we show that GSG1L’s spatiotemporal expression, native interactome and allosteric sites are distinct. GSG1L generally expresses late during brain development in a region-specific manner, constituting about 5% of all AMPAR complexes in adulthood. While GSG1L can co-assemble with TARPs or cornichons (CNIHs), it also assembles as the sole auxiliary subunit. Unexpectedly, GSG1L acts through two discrete evolutionarily-conserved sites on the agonist-binding domain with a weak allosteric interaction at the TARP/KGK site to slow desensitization, and a stronger interaction at a different site that slows recovery from desensitization. Together, these distinctions help explain GSG1L’s evolutionary past and how it fulfills a unique signaling role within glutamatergic synapses.

TARPs and GSG1L are evolutionarily- and structurally-related AMPA receptor auxiliary subunits that differ in function through unresolved mechanisms. Here, the authors provide insight into the spatiotemporal expression, composition, and functionality of GSG1L-containing protein complexes.

Details

Title
GSG1L-containing AMPA receptor complexes are defined by their spatiotemporal expression, native interactome and allosteric sites
Author
Perozzo, Amanda M. 1   VIAFID ORCID Logo  ; Schwenk, Jochen 2   VIAFID ORCID Logo  ; Kamalova, Aichurok 3 ; Nakagawa, Terunaga 4 ; Fakler, Bernd 5   VIAFID ORCID Logo  ; Bowie, Derek 6   VIAFID ORCID Logo 

 McGill University, Integrated Program in Neuroscience, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Pharmacology and Therapeutics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 University of Freiburg, Institute of Physiology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203) 
 Vanderbilt University School of Medicine, Department of Molecular Physiology and Biophysics, Vanderbilt Brain Institute, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217) 
 Vanderbilt University School of Medicine, Department of Molecular Physiology and Biophysics, Vanderbilt Brain Institute, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Center for Structural Biology, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217) 
 University of Freiburg, Institute of Physiology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); University of Freiburg, Schänzlestr. 18, Signaling Research Centers BIOSS and CIBSS, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203) 
 McGill University, Department of Pharmacology and Therapeutics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
Pages
6799
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2882124355
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.